Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 81,406 | 80,748 | 111,108 | -13,729 | 106,693 |
| Cost of Goods | N/A | N/A | 24,519 | N/A | 27,541 |
| Gross Profit | 81,406 | 80,748 | 86,589 | 56,807 | 79,152 |
| Operating Expenses | 67,897 | 50,122 | 42,987 | -52,899 | 40,044 |
| Operating Income | 13,509 | 30,626 | 44,121 | 39,170 | 39,649 |
| Interest Expense | 23,102 | 23,209 | 23,850 | 15,269 | 15,811 |
| Other Income | -380 | -119 | -38 | -167 | -116 |
| Pre-tax Income | -9,973 | 7,298 | 20,233 | 23,734 | 23,722 |
| Income Tax | -4,830 | 583 | 1,659 | 2,125 | 1,403 |
| Net Income Continuous | -5,143 | 6,715 | 18,574 | 21,609 | 22,319 |
| Net Income Discontinuous | -636 | -1,221 | N/A | -2,202 | -565 |
| Net Income | $-5,779 | $5,494 | $18,574 | $19,407 | $21,754 |
| EPS Basic Total Ops | -0.46 | 0.19 | 0.88 | 0.90 | 1.04 |
| EPS Basic Continuous Ops | -0.42 | 0.26 | 1.00 | 1.01 | 1.07 |
| EPS Basic Discontinuous Ops | -0.04 | -0.07 | N/A | -0.11 | -0.03 |
| EPS Diluted Total Ops | -0.46 | 0.18 | 0.87 | 0.88 | 1.03 |
| EPS Diluted Continuous Ops | -0.42 | 0.25 | 0.98 | 0.98 | 1.06 |
| EPS Diluted Discontinuous Ops | -0.04 | -0.07 | N/A | -0.10 | -0.03 |
| EBITDA(a) | $42,735 | $61,199 | $77,565 | $66,674 | $68,718 |